News center_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

06-07

InnoModels Biotechnology: What are the features and advantages of the ADCC platform?

In today's era of rapid development of biotechnology, InnoModels' ADCC platform is leading a new era of drug development and clinical treatment with its unique features and advantages. The platform not only has a diversified experimental service system, but also focuses on simulating the in vivo environment to provide researchers with accurate and reliable data support. In the following, we will introduce the features of InnoModels' ADCC platform in detail.

06-06

InnoModels Biotechnology: What are the features of the CDX platform?

With the rapid development in the field of biomedicine, cancer research and treatment has entered a brand new era. In this era, an efficient and precise experimental platform has become the key for scientists to overcome cancer. The InnoModels Biotechnology CDX platform was born out of necessity, and with its unique features and advantages, it is gradually becoming a new favorite in the field of cancer research and treatment.

06-05

InnoModels Biotechnology: What are the features of the iHuPBMC-OncVax platform?

In today's era of continuous integration of biotechnology and medical field, personalized medicine has gradually become the focus of people's attention. With its profound accumulation in the field of biotechnology and immunotherapy, InnoModels Biotechnology has successfully developed the iHuPBMC-OncVax platform, which, with its unique features and advantages, brings unprecedented possibilities for tumor immunotherapy.

06-04

InnoModels Biotechnology: What are the features of the iHuPBMC-B platform?

In the field of modern biomedicine, the importance of immune system research is self-evident. It is not only the body's first line of defense against external pathogens, but also the key to the treatment and prevention of many diseases. In order to meet the growing demand for research in this field, InnoModels Biotechnology has brought a revolutionary breakthrough in immunology research with its iHuPBMC-B platform.

< 1...18 19 20...62 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License